Prolocum Pharm Limited 05353554 false 2022-03-01 2023-02-28 2023-02-28 The principal activity of the company is providing locum pharmaceutical services Digita Accounts Production Advanced 6.30.9574.0 true 05353554 2022-03-01 2023-02-28 05353554 2023-02-28 05353554 core:RetainedEarningsAccumulatedLosses 2023-02-28 05353554 core:ShareCapital 2023-02-28 05353554 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 05353554 core:FurnitureFittingsToolsEquipment 2023-02-28 05353554 bus:SmallEntities 2022-03-01 2023-02-28 05353554 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 05353554 bus:FullAccounts 2022-03-01 2023-02-28 05353554 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 05353554 bus:RegisteredOffice 2022-03-01 2023-02-28 05353554 bus:CompanySecretary1 2022-03-01 2023-02-28 05353554 bus:Director2 2022-03-01 2023-02-28 05353554 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 05353554 core:ComputerEquipment 2022-03-01 2023-02-28 05353554 core:FurnitureFittingsToolsEquipment 2022-03-01 2023-02-28 05353554 countries:EnglandWales 2022-03-01 2023-02-28 05353554 2022-02-28 05353554 core:FurnitureFittingsToolsEquipment 2022-02-28 05353554 2021-03-01 2022-02-28 05353554 2022-02-28 05353554 core:RetainedEarningsAccumulatedLosses 2022-02-28 05353554 core:ShareCapital 2022-02-28 05353554 core:CurrentFinancialInstruments core:WithinOneYear 2022-02-28 05353554 core:FurnitureFittingsToolsEquipment 2022-02-28 iso4217:GBP xbrli:pure

Registration number: 05353554

Prolocum Pharm Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 28 February 2023

image-name
 

Prolocum Pharm Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

Prolocum Pharm Limited

Company Information

Director

Miss Saeqa Rehman

Company secretary

Lucraft Secretarial Limited

Registered office

Ground Floor
19 New Road
Brighton
East Sussex
BN1 1UF

Accountants

Lucraft Hodgson & Dawes LLP
Ground Floor
19 New Road
Brighton
East Sussex
BN1 1UF

 

Prolocum Pharm Limited

(Registration number: 05353554)
Balance Sheet as at 28 February 2023

Note

2023
 £

2022
 £

Fixed Assets

 

Tangible Assets

3

268

357

Current assets

 

Cash at bank and in hand

 

96,043

77,049

Creditors: Amounts falling due within one year

4

(78,823)

(68,888)

Net current assets

 

17,220

8,161

Total assets less current liabilities

 

17,488

8,518

Provisions for liabilities

(51)

(67)

Net assets

 

17,437

8,451

Capital and Reserves

 

Called up share capital

1

1

Profit and loss account

17,436

8,450

Total equity

 

17,437

8,451

For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 27 November 2023
 

.........................................
Miss Saeqa Rehman
Director

   
     
 

Prolocum Pharm Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

1

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in Sterling, which is the functional currency of the company.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

25% on reducing balance

 

Prolocum Pharm Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, analysed by category was as follows:

2023
 No.

2022
 No.

Administration and support

1

1

1

1

3

Tangible Assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 March 2022

1,008

1,008

At 28 February 2023

1,008

1,008

Depreciation

At 1 March 2022

651

651

Charge for the year

89

89

At 28 February 2023

740

740

Carrying amount

At 28 February 2023

268

268

At 28 February 2022

357

357

 

Prolocum Pharm Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

4

Creditors

Creditors: amounts falling due within one year

Note

2023
 £

2022
 £

Due within one year

 

Loans and borrowings

71,006

62,009

Accrued expenses

 

1,000

900

Corporation tax liability

6,817

5,979

 

78,823

68,888